{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:46:34Z","timestamp":1778150794379,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic subdural hematoma (cSDH) is a common neurosurgical condition that is prevalent in elderly patients. There are no well-defined guidelines for cSDH and management strategies vary widely among physicians and institutions, and this variability is expressed in the literature. In general, conservative management is reserved to patients who are asymptomatic or have minor symptoms with mild mass effect. Spontaneous resolution of cSDH is an unusual phenomenon and middle meningeal artery (MMA) embolization seems to reduce the recurrence and progression rate of SDH compared to conventional treatments in multiple cohort studies. A randomized controlled trial is warranted to determine the effectiveness and safety of endovascular embolization for cSDH and whether MMA embolization is superior to conservative management in reducing the progression rate and surgical rescue event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is an Italian multicenter prospective randomized clinical trial with open-label treatment and blinded outcome assessment (PROBE design) to assess the superiority of MMA embolization compared to conservative treatment. A total of 300 patients are planned to be randomized 1:1 to receive MMA embolization (intervention) or conventional treatments (control). The primary outcome is the treatment arm failure which is defined as a composite of incomplete hematoma resolution or surgical rescue within 6 months follow-up. Incomplete hematoma resolution is defined as a reduction of the cSDH thickness \u226450% at follow-up compared to the hematoma thickness measured at the time of randomization. Surgical rescue is intended as hematoma removal for relief or symptoms that developed with continuous growth of the cSDH. In case of bilateral cSDH, the treatment failure occurred when primary outcomes criteria are satisfied for at least one of the two hematomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This multi-centre randomized controlled trial is needed to evaluate the benefit-to-risk ratio of primary embolization of the MMA to facilitate resolution and prevent rescue surgical evacuation of cSDH. If MMA embolization turns out to be superior to conservative management in this trial, this may prompt further confirmatory trials and, at best, may change clinical practice and guideline recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov. Identifier: NCT06274580, Registered on 6 February 2024. This protocol was developed in accordance with the SPIRIT Checklist and by use of the structured study protocol template provided by BMC Trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-025-09131-y","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:17:44Z","timestamp":1763461064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endovascular vs conservative treatment in patients with chronic subdural hematomas and mild symptoms: a study protocol for a multicenter randomized controlled trial (EMBOTRIAL-1)"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-7952","authenticated-orcid":false,"given":"Giancarlo","family":"Salsano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Fiaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorello","family":"Laura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mammoliti","family":"Sonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Boni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Zona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Castellan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"16","key":"9131_CR1","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1089\/neu.2018.5872","volume":"35","author":"C Iorio-Morin","year":"2018","unstructured":"Iorio-Morin C, Touchette C, L\u00e9vesque M, Effendi K, Fortin D, Mathieu D. Chronic subdural hematoma: toward a new management paradigm for an increasingly complex population. J Neurotrauma. 2018;35(16):1882\u20135. https:\/\/doi.org\/10.1089\/neu.2018.5872.","journal-title":"J Neurotrauma"},{"issue":"1","key":"9131_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3171\/2016.9.JNS16623","volume":"128","author":"T Hiroyuki","year":"2018","unstructured":"Hiroyuki T, Kinoshita K, Hirai S, Takai H, Hara K, Matsushita N, et al. Present epidemiology of chronic subdural hematoma in Japan: analysis of 63,358 cases recorded in a national administrative database. J Neurosurg. 2018;128(1):222\u20138. https:\/\/doi.org\/10.3171\/2016.9.JNS16623.","journal-title":"J Neurosurg"},{"key":"9131_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12974-017-0881-y","volume":"14","author":"E Edlmann","year":"2017","unstructured":"Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14:108. https:\/\/doi.org\/10.1186\/s12974-017-0881-y.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"9131_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.nec.2016.11.002","volume":"28","author":"W Yang","year":"2017","unstructured":"Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am. 2017;28(2):205\u201310. https:\/\/doi.org\/10.1016\/j.nec.2016.11.002.","journal-title":"Neurosurg Clin N Am"},{"key":"9131_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2021.100300","author":"A Nouri","year":"2021","unstructured":"Nouri A, Gondar R, Schaller K, Meling T. Chronic subdural hematoma (cSDH): a review of the current state of the art. Brain and Spine. 2021. https:\/\/doi.org\/10.1016\/j.bas.2021.100300.","journal-title":"Brain and Spine"},{"issue":"6","key":"9131_CR6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/01.STR.0000017219.83330.FF","volume":"33","author":"R Gerlach","year":"2002","unstructured":"Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33(6):1618\u201323.","journal-title":"Stroke"},{"issue":"3","key":"9131_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/jns.1981.55.3.0390","volume":"55","author":"TM Markwalder","year":"1981","unstructured":"Markwalder TM, Steinsiepe KF, Rohner M, Reichenbach W, Markwalder H. The course of chronic subdural hematomas after burr-hole craniostomy and closed-system drainage. J Neurosurg. 1981;55(3):390\u20136. https:\/\/doi.org\/10.3171\/jns.1981.55.3.0390.","journal-title":"J Neurosurg"},{"issue":"1","key":"9131_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-021-00263-z","volume":"7","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chinese Society of Neurosurgery, Chinese Medical Association, Chinese Neurosurgical Critical Care Specialist Council, Collaborational Group of Chinese Neurosurgical Translational and Evidence-based Medicine. Expert consensus on drug treatment of chronic subdural hematoma. Chin Neurosurg J. 2021;7(1):47. https:\/\/doi.org\/10.1186\/s41016-021-00263-z.","journal-title":"Chin Neurosurg J"},{"issue":"9695","key":"9131_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(09)61115-6","volume":"374","author":"T Santarius","year":"2009","unstructured":"Santarius T, Kirkpatrick PJ, Ganesan D, Chia HL, Jalloh I, Smielewski P, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet. 2009;374(9695):1067\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(09)61115-6.","journal-title":"Lancet"},{"key":"9131_CR10","doi-asserted-by":"publisher","unstructured":"Horikoshi T, Naganuma H, Fukasawa I, Uchida M, Nukui H. Computed tomography characteristics suggestive of spontaneous resolution of chronic subdural hematoma. Neurol. Med. Chir (Tokyo). 1988;38:527\u2013532. https:\/\/doi.org\/10.2176\/nmc.38.527.","DOI":"10.2176\/nmc.38.527"},{"issue":"6","key":"9131_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3340\/jkns.2016.59.6.628","volume":"59","author":"HC Kim","year":"2016","unstructured":"Kim HC, Ko JH, Yoo DS, Lee SH. Spontaneous Resolution of Chronic Subdural Hematoma: Close Observation as a Treatment Strategy. J Korean Neurosurg Soc. 2016;59(6):628\u201336. https:\/\/doi.org\/10.3340\/jkns.2016.59.6.628.","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"9131_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1017\/cjn.2015.393","volume":"43","author":"M Prud\u2019homme","year":"2016","unstructured":"Prud\u2019homme M, Mathieu F, Marcotte N, Cottin S. A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma. Can J Neurol Sci. 2016;43(2):284\u201390. https:\/\/doi.org\/10.1017\/cjn.2015.393.","journal-title":"Can J Neurol Sci"},{"key":"9131_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.clineuro.2014.05.003","volume":"123","author":"FR Poulsen","year":"2014","unstructured":"Poulsen FR, Munthe S, S\u00f8e M, Halle B. Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: a randomized trial. Clin Neurol Neurosurg. 2014;123:4\u20138. https:\/\/doi.org\/10.1016\/j.clineuro.2014.05.003.","journal-title":"Clin Neurol Neurosurg"},{"key":"9131_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2015.12.JNS151991","volume":"29","author":"H Liu","year":"2016","unstructured":"Liu H, Liu Z, Liu Y, Kan S, Yang J, Liu H. Effect of atorvastatin on resolution of chronic subdural hematoma: a prospective observational study [RETRACTED]. J Neurosurg. 2016;29:1\u201310. https:\/\/doi.org\/10.3171\/2015.12.JNS151991.","journal-title":"J Neurosurg"},{"issue":"4","key":"9131_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/1591019918769336","volume":"24","author":"TW Link","year":"2018","unstructured":"Link TW, Rapoport BI, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: endovascular technique and radiographics findings. Interv Neuroradiol. 2018;24(4):455\u201362. https:\/\/doi.org\/10.1177\/1591019918769336.","journal-title":"Interv Neuroradiol"},{"issue":"10","key":"9131_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/neurintsurg-2021-017352","volume":"13","author":"N Ironside","year":"2021","unstructured":"Ironside N, Nguyen C, Do Q, Ugiliweneza B, Chen CJ, Sieg EP, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis. J Neurointerv Surg. 2021;13(10):951\u20137. https:\/\/doi.org\/10.1136\/neurintsurg-2021-017352.","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"9131_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/15910199221125977","volume":"30","author":"S Abdollahifard","year":"2022","unstructured":"Abdollahifard S, Farrokhi A, Yousefi O, Valibeygi A, Azami P, Mowla A. Particle embolic agents for embolization of middle meningeal artery in the treatment of chronic subdural hematoma: a systematic review and meta-analysis. Interv Neuroradiol. 2022;30(1):15910199221125977. https:\/\/doi.org\/10.1177\/15910199221125977.","journal-title":"Interv Neuroradiol"},{"issue":"3","key":"9131_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1148\/radiol.2017170053","volume":"286","author":"SP Ban","year":"2018","unstructured":"Ban SP, Hwang G, Byoun HS, Kim T, Lee SU, Bang JS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology. 2018;286(3):992\u20139. https:\/\/doi.org\/10.1148\/radiol.2017170053.","journal-title":"Radiology"},{"key":"9131_CR19","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/j.wneu.2018.04.208","volume":"116","author":"CJ Przybylowski","year":"2018","unstructured":"Przybylowski CJ, Baranoski JF, See AP, Flores BC, Almefty RO, Ding D, et al. Preoperative embolization of skull base meningiomas: outcomes in the Onyx era. World Neurosurg. 2018;116:e371\u20139. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.208.","journal-title":"World Neurosurg"},{"key":"9131_CR20","doi-asserted-by":"publisher","unstructured":"Wilson JL, Hareendran A, Hendry A, Potter J, Bone I, Muir KW. Reliability of the modifed Rankin Scale across multiple raters: benefts of a structured interview. Stroke. 36(4):777\u201381. https:\/\/doi.org\/10.1161\/01.STR.0000157596.13234.","DOI":"10.1161\/01.STR.0000157596.13234"},{"issue":"7","key":"9131_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/neurintsurg-2020-016552","volume":"13","author":"JS Catapano","year":"2021","unstructured":"Catapano JS, Ducruet AF, Nguyen CL, Baranoski JF, Cole TS, Majmundar N, et al. Middle meningeal artery embolization for chronic subdural hematoma: an institutional technical analysis. J Neurointerv Surg. 2021;13(7):657\u201360. https:\/\/doi.org\/10.1136\/neurintsurg-2020-016552.","journal-title":"J Neurointerv Surg"},{"issue":"11","key":"9131_CR22","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jamaneurol.2018.2030","volume":"75","author":"R Jiang","year":"2018","unstructured":"Jiang R, Zhao S, Wang R, Feng H, Zhang J, Li X, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized clinicaltrial. JAMA Neurol. 2018;75(11):1338\u201346. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2030.","journal-title":"JAMA Neurol"},{"issue":"6","key":"9131_CR23","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/neuros\/nyy521","volume":"85","author":"TW Link","year":"2019","unstructured":"Link TW, Boddu S, Paine SM, Kamel H, Knopman J. Middle meningeal artery embolization for chronic subdural hematoma: a series of 60 cases. Neurosurgery. 2019;85(6):801\u20137. https:\/\/doi.org\/10.1093\/neuros\/nyy521.","journal-title":"Neurosurgery"},{"issue":"3","key":"9131_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/neurintsurg-2021-017450","volume":"14","author":"C Onyinzo","year":"2022","unstructured":"Onyinzo C, Berlis A, Abel M, Kudernatsch M, Maurer CJ. Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone. J Neurointerv Surg. 2022;14(3):297\u2013300. https:\/\/doi.org\/10.1136\/neurintsurg-2021-017450.","journal-title":"J Neurointerv Surg"},{"issue":"2","key":"9131_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing 4 translational research informatics support. J Biomed Inform. 2009;42(2):377-381. 5. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"9131_CR26","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (November 2016), Guidline for Good Clinical Practice, www.ich.org. Accessed 2 Oct 2019."},{"key":"9131_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12885-016-2408-9","volume":"16","author":"S Zhang","year":"2016","unstructured":"Zhang S, Liang F, Tannock I. Use and misuse of common terminology criteria for adverse events in cancer clinical trials. BMC Cancer. 2016;16:392. https:\/\/doi.org\/10.1186\/s12885-016-2408-9.","journal-title":"BMC Cancer"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09131-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09131-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:17:45Z","timestamp":1763461065000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09131-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9131"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09131-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"4 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study will be conducted in accordance with the principles of the Helsinki Declaration and Good Clinical Practice. It was approved by the Ethics Committee of the IRCCS Ospedale Policlinico San Martino (Application Number: 107\/2023 - DB id 12994) at 29 May 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Written informed consent will be obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"517"}}